Please login to the form below

Not currently logged in
Email:
Password:

gantenerumab

This page shows the latest gantenerumab news and features for those working in and with pharma, biotech and healthcare.

Another amyloid bust as Roche pulls crenezumab trials

Another amyloid bust as Roche pulls crenezumab trials

Meanwhile, Roche is independently developing another amyloid-target drug called gantenerumab in phase 3, despite disappointing data in a mid-stage study.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics